Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PYRAZINAMIDE Cause Neuropathy peripheral? 188 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 188 reports of Neuropathy peripheral have been filed in association with PYRAZINAMIDE (Pyrazinamide). This represents 3.4% of all adverse event reports for PYRAZINAMIDE.

188
Reports of Neuropathy peripheral with PYRAZINAMIDE
3.4%
of all PYRAZINAMIDE reports
23
Deaths
57
Hospitalizations

How Dangerous Is Neuropathy peripheral From PYRAZINAMIDE?

Of the 188 reports, 23 (12.2%) resulted in death, 57 (30.3%) required hospitalization, and 5 (2.7%) were considered life-threatening.

Is Neuropathy peripheral Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PYRAZINAMIDE. However, 188 reports have been filed with the FAERS database.

What Other Side Effects Does PYRAZINAMIDE Cause?

Drug-induced liver injury (588) Drug reaction with eosinophilia and systemic symptoms (492) Paradoxical drug reaction (407) Vomiting (307) Pyrexia (301) Drug ineffective (298) Off label use (288) Hepatotoxicity (279) Drug resistance (269) Nausea (251)

What Other Drugs Cause Neuropathy peripheral?

LENALIDOMIDE (10,215) BORTEZOMIB (4,067) OXALIPLATIN (3,662) DEXAMETHASONE (3,543) PACLITAXEL (3,508) LEVOFLOXACIN (2,619) CIPROFLOXACIN (2,607) FLUOROURACIL (2,605) CYCLOPHOSPHAMIDE (2,565) POMALIDOMIDE (2,382)

Which PYRAZINAMIDE Alternatives Have Lower Neuropathy peripheral Risk?

PYRAZINAMIDE vs PYRIDOSTIGMINE PYRAZINAMIDE vs PYRIDOXINE PYRAZINAMIDE vs PYRIDOXINE\THIAMINE PYRAZINAMIDE vs PYRIMETHAMINE PYRAZINAMIDE vs PYROTINIB

Related Pages

PYRAZINAMIDE Full Profile All Neuropathy peripheral Reports All Drugs Causing Neuropathy peripheral PYRAZINAMIDE Demographics